Global Microbiome Therapeutics Market Report 2019, Competitive Landscape, Trends and Opportunities
The Microbiome Therapeutics market has witnessed growth from USD XX million to USD XX million from 2014 to 2019. With the CAGR of X.X%, this market is estimated to reach USD XX million in 2026.
The report mainly studies the size, recent trends and development status of the Microbiome Therapeutics market, as well as investment opportunities, government policy, market dynamics (drivers, restraints, opportunities), supply chain and competitive landscape. Technological innovation and advancement will further optimize the performance of the product, making it more widely used in downstream applications. Moreover, Porter's Five Forces Analysis (potential entrants, suppliers, substitutes, buyers, industry competitors) provides crucial information for knowing the Microbiome Therapeutics market.
Major players in the global Microbiome Therapeutics market include:
Assembly Biosciences
MicroBiome Therapeutics
APC Microbiome Institute
AgBiome
Admera Health
AbbVie
Enterome Bioscience
Advanced Technology Ventures
Immuron
Azitra
Osel
Synthetic Biologics
ActoGeniX
C3 Jian
4D Pharma
AOBiome
Ritter Pharmaceuticals
OpenBiome
Advancing Bio
Seres Therapeutics
Second Genome
Avid Biotics
On the basis of types, the Microbiome Therapeutics market is primarily split into:
Fructo-Oligosaccharides
Galacto-Oligosaccharides
Inulin
On the basis of applications, the market covers:
Antibiotic-Associated Diarrhoea (AAD)
Infectious Childhood Diarrhoea
Cholesterol
Inflammatory Bowel Disease (IBD)
Blood Pressure
Lactose Intolerance
Weight Loss
Vitamin Production
Bacterial Vaginosis (BV)
Others
Geographically, the report includes the research on production, consumption, revenue, market share and growth rate, and forecast (2014-2026) of the following regions:
United States
Europe (Germany, UK, France, Italy, Spain, Russia, Poland)
China
Japan
India
Southeast Asia (Malaysia, Singapore, Philippines, Indonesia, Thailand, Vietnam)
Central and South America (Brazil, Mexico, Colombia)
Middle East and Africa (Saudi Arabia, United Arab Emirates, Turkey, Egypt, South Africa, Nigeria)
Other Regions
Chapter 1 provides an overview of Microbiome Therapeutics market, containing global revenue, global production, sales, and CAGR. The forecast and analysis of Microbiome Therapeutics market by type, application, and region are also presented in this chapter.
Chapter 2 is about the market landscape and major players. It provides competitive situation and market concentration status along with the basic information of these players.
Chapter 3 provides a full-scale analysis of major players in Microbiome Therapeutics industry. The basic information, as well as the profiles, applications and specifications of products market performance along with Business Overview are offered.
Chapter 4 gives a worldwide view of Microbiome Therapeutics market. It includes production, market share revenue, price, and the growth rate by type.
Chapter 5 focuses on the application of Microbiome Therapeutics, by analyzing the consumption and its growth rate of each application.
Chapter 6 is about production, consumption, export, and import of Microbiome Therapeutics in each region.
Chapter 7 pays attention to the production, revenue, price and gross margin of Microbiome Therapeutics in markets of different regions. The analysis on production, revenue, price and gross margin of the global market is covered in this part.
Chapter 8 concentrates on manufacturing analysis, including key raw material analysis, cost structure analysis and process analysis, making up a comprehensive analysis of manufacturing cost.
Chapter 9 introduces the industrial chain of Microbiome Therapeutics. Industrial chain analysis, raw material sources and downstream buyers are analyzed in this chapter.
Chapter 10 provides clear insights into market dynamics.
Chapter 11 prospects the whole Microbiome Therapeutics market, including the global production and revenue forecast, regional forecast. It also foresees the Microbiome Therapeutics market by type and application.
Chapter 12 concludes the research findings and refines all the highlights of the study.
Chapter 13 introduces the research methodology and sources of research data for your understanding.
Years considered for this report:
Historical Years: 2014-2018
Base Year: 2019
Estimated Year: 2019
Forecast Period: 2019-2026
The report mainly studies the size, recent trends and development status of the Microbiome Therapeutics market, as well as investment opportunities, government policy, market dynamics (drivers, restraints, opportunities), supply chain and competitive landscape. Technological innovation and advancement will further optimize the performance of the product, making it more widely used in downstream applications. Moreover, Porter's Five Forces Analysis (potential entrants, suppliers, substitutes, buyers, industry competitors) provides crucial information for knowing the Microbiome Therapeutics market.
Major players in the global Microbiome Therapeutics market include:
Assembly Biosciences
MicroBiome Therapeutics
APC Microbiome Institute
AgBiome
Admera Health
AbbVie
Enterome Bioscience
Advanced Technology Ventures
Immuron
Azitra
Osel
Synthetic Biologics
ActoGeniX
C3 Jian
4D Pharma
AOBiome
Ritter Pharmaceuticals
OpenBiome
Advancing Bio
Seres Therapeutics
Second Genome
Avid Biotics
On the basis of types, the Microbiome Therapeutics market is primarily split into:
Fructo-Oligosaccharides
Galacto-Oligosaccharides
Inulin
On the basis of applications, the market covers:
Antibiotic-Associated Diarrhoea (AAD)
Infectious Childhood Diarrhoea
Cholesterol
Inflammatory Bowel Disease (IBD)
Blood Pressure
Lactose Intolerance
Weight Loss
Vitamin Production
Bacterial Vaginosis (BV)
Others
Geographically, the report includes the research on production, consumption, revenue, market share and growth rate, and forecast (2014-2026) of the following regions:
United States
Europe (Germany, UK, France, Italy, Spain, Russia, Poland)
China
Japan
India
Southeast Asia (Malaysia, Singapore, Philippines, Indonesia, Thailand, Vietnam)
Central and South America (Brazil, Mexico, Colombia)
Middle East and Africa (Saudi Arabia, United Arab Emirates, Turkey, Egypt, South Africa, Nigeria)
Other Regions
Chapter 1 provides an overview of Microbiome Therapeutics market, containing global revenue, global production, sales, and CAGR. The forecast and analysis of Microbiome Therapeutics market by type, application, and region are also presented in this chapter.
Chapter 2 is about the market landscape and major players. It provides competitive situation and market concentration status along with the basic information of these players.
Chapter 3 provides a full-scale analysis of major players in Microbiome Therapeutics industry. The basic information, as well as the profiles, applications and specifications of products market performance along with Business Overview are offered.
Chapter 4 gives a worldwide view of Microbiome Therapeutics market. It includes production, market share revenue, price, and the growth rate by type.
Chapter 5 focuses on the application of Microbiome Therapeutics, by analyzing the consumption and its growth rate of each application.
Chapter 6 is about production, consumption, export, and import of Microbiome Therapeutics in each region.
Chapter 7 pays attention to the production, revenue, price and gross margin of Microbiome Therapeutics in markets of different regions. The analysis on production, revenue, price and gross margin of the global market is covered in this part.
Chapter 8 concentrates on manufacturing analysis, including key raw material analysis, cost structure analysis and process analysis, making up a comprehensive analysis of manufacturing cost.
Chapter 9 introduces the industrial chain of Microbiome Therapeutics. Industrial chain analysis, raw material sources and downstream buyers are analyzed in this chapter.
Chapter 10 provides clear insights into market dynamics.
Chapter 11 prospects the whole Microbiome Therapeutics market, including the global production and revenue forecast, regional forecast. It also foresees the Microbiome Therapeutics market by type and application.
Chapter 12 concludes the research findings and refines all the highlights of the study.
Chapter 13 introduces the research methodology and sources of research data for your understanding.
Years considered for this report:
Historical Years: 2014-2018
Base Year: 2019
Estimated Year: 2019
Forecast Period: 2019-2026
1 MICROBIOME THERAPEUTICS MARKET OVERVIEW
1.1 Product Overview and Scope of Microbiome Therapeutics
1.2 Microbiome Therapeutics Segment by Type
1.2.1 Global Microbiome Therapeutics Production and CAGR (%) Comparison by Type (2014-2026)
1.2.2 The Market Profile of Fructo-Oligosaccharides
1.2.3 The Market Profile of Galacto-Oligosaccharides
1.2.4 The Market Profile of Inulin
1.3 Global Microbiome Therapeutics Segment by Application
1.3.1 Microbiome Therapeutics Consumption (Sales) Comparison by Application (2014-2026)
1.3.2 The Market Profile of Antibiotic-Associated Diarrhoea (AAD)
1.3.3 The Market Profile of Infectious Childhood Diarrhoea
1.3.4 The Market Profile of Cholesterol
1.3.5 The Market Profile of Inflammatory Bowel Disease (IBD)
1.3.6 The Market Profile of Blood Pressure
1.3.7 The Market Profile of Lactose Intolerance
1.3.8 The Market Profile of Weight Loss
1.3.9 The Market Profile of Vitamin Production
1.3.10 The Market Profile of Bacterial Vaginosis (BV)
1.3.11 The Market Profile of Others
1.4 Global Microbiome Therapeutics Market by Region (2014-2026)
1.4.1 Global Microbiome Therapeutics Market Size (Value) and CAGR (%) Comparison by Region (2014-2026)
1.4.2 United States Microbiome Therapeutics Market Status and Prospect (2014-2026)
1.4.3 Europe Microbiome Therapeutics Market Status and Prospect (2014-2026)
1.4.3.1 Germany Microbiome Therapeutics Market Status and Prospect (2014-2026)
1.4.3.2 UK Microbiome Therapeutics Market Status and Prospect (2014-2026)
1.4.3.3 France Microbiome Therapeutics Market Status and Prospect (2014-2026)
1.4.3.4 Italy Microbiome Therapeutics Market Status and Prospect (2014-2026)
1.4.3.5 Spain Microbiome Therapeutics Market Status and Prospect (2014-2026)
1.4.3.6 Russia Microbiome Therapeutics Market Status and Prospect (2014-2026)
1.4.3.7 Poland Microbiome Therapeutics Market Status and Prospect (2014-2026)
1.4.4 China Microbiome Therapeutics Market Status and Prospect (2014-2026)
1.4.5 Japan Microbiome Therapeutics Market Status and Prospect (2014-2026)
1.4.6 India Microbiome Therapeutics Market Status and Prospect (2014-2026)
1.4.7 Southeast Asia Microbiome Therapeutics Market Status and Prospect (2014-2026)
1.4.7.1 Malaysia Microbiome Therapeutics Market Status and Prospect (2014-2026)
1.4.7.2 Singapore Microbiome Therapeutics Market Status and Prospect (2014-2026)
1.4.7.3 Philippines Microbiome Therapeutics Market Status and Prospect (2014-2026)
1.4.7.4 Indonesia Microbiome Therapeutics Market Status and Prospect (2014-2026)
1.4.7.5 Thailand Microbiome Therapeutics Market Status and Prospect (2014-2026)
1.4.7.6 Vietnam Microbiome Therapeutics Market Status and Prospect (2014-2026)
1.4.8 Central and South America Microbiome Therapeutics Market Status and Prospect (2014-2026)
1.4.8.1 Brazil Microbiome Therapeutics Market Status and Prospect (2014-2026)
1.4.8.2 Mexico Microbiome Therapeutics Market Status and Prospect (2014-2026)
1.4.8.3 Colombia Microbiome Therapeutics Market Status and Prospect (2014-2026)
1.4.9 Middle East and Africa Microbiome Therapeutics Market Status and Prospect (2014-2026)
1.4.9.1 Saudi Arabia Microbiome Therapeutics Market Status and Prospect (2014-2026)
1.4.9.2 United Arab Emirates Microbiome Therapeutics Market Status and Prospect (2014-2026)
1.4.9.3 Turkey Microbiome Therapeutics Market Status and Prospect (2014-2026)
1.4.9.4 Egypt Microbiome Therapeutics Market Status and Prospect (2014-2026)
1.4.9.5 South Africa Microbiome Therapeutics Market Status and Prospect (2014-2026)
1.4.9.6 Nigeria Microbiome Therapeutics Market Status and Prospect (2014-2026)
1.5 Global Market Size (Value) of Microbiome Therapeutics (2014-2026)
1.5.1 Global Microbiome Therapeutics Revenue Status and Outlook (2014-2026)
1.5.2 Global Microbiome Therapeutics Production Status and Outlook (2014-2026)
2 GLOBAL MICROBIOME THERAPEUTICS MARKET LANDSCAPE BY PLAYER
2.1 Global Microbiome Therapeutics Production and Share by Player (2014-2019)
2.2 Global Microbiome Therapeutics Revenue and Market Share by Player (2014-2019)
2.3 Global Microbiome Therapeutics Average Price by Player (2014-2019)
2.4 Microbiome Therapeutics Manufacturing Base Distribution, Sales Area and Product Type by Player
2.5 Microbiome Therapeutics Market Competitive Situation and Trends
2.5.1 Microbiome Therapeutics Market Concentration Rate
2.5.2 Microbiome Therapeutics Market Share of Top 3 and Top 6 Players
2.5.3 Mergers & Acquisitions, Expansion
3 PLAYERS PROFILES
3.1 Assembly Biosciences
3.1.1 Assembly Biosciences Basic Information, Manufacturing Base, Sales Area and Competitors
3.1.2 Microbiome Therapeutics Product Profiles, Application and Specification
3.1.3 Assembly Biosciences Microbiome Therapeutics Market Performance (2014-2019)
3.1.4 Assembly Biosciences Business Overview
3.2 MicroBiome Therapeutics
3.2.1 MicroBiome Therapeutics Basic Information, Manufacturing Base, Sales Area and Competitors
3.2.2 Microbiome Therapeutics Product Profiles, Application and Specification
3.2.3 MicroBiome Therapeutics Microbiome Therapeutics Market Performance (2014-2019)
3.2.4 MicroBiome Therapeutics Business Overview
3.3 APC Microbiome Institute
3.3.1 APC Microbiome Institute Basic Information, Manufacturing Base, Sales Area and Competitors
3.3.2 Microbiome Therapeutics Product Profiles, Application and Specification
3.3.3 APC Microbiome Institute Microbiome Therapeutics Market Performance (2014-2019)
3.3.4 APC Microbiome Institute Business Overview
3.4 AgBiome
3.4.1 AgBiome Basic Information, Manufacturing Base, Sales Area and Competitors
3.4.2 Microbiome Therapeutics Product Profiles, Application and Specification
3.4.3 AgBiome Microbiome Therapeutics Market Performance (2014-2019)
3.4.4 AgBiome Business Overview
3.5 Admera Health
3.5.1 Admera Health Basic Information, Manufacturing Base, Sales Area and Competitors
3.5.2 Microbiome Therapeutics Product Profiles, Application and Specification
3.5.3 Admera Health Microbiome Therapeutics Market Performance (2014-2019)
3.5.4 Admera Health Business Overview
3.6 AbbVie
3.6.1 AbbVie Basic Information, Manufacturing Base, Sales Area and Competitors
3.6.2 Microbiome Therapeutics Product Profiles, Application and Specification
3.6.3 AbbVie Microbiome Therapeutics Market Performance (2014-2019)
3.6.4 AbbVie Business Overview
3.7 Enterome Bioscience
3.7.1 Enterome Bioscience Basic Information, Manufacturing Base, Sales Area and Competitors
3.7.2 Microbiome Therapeutics Product Profiles, Application and Specification
3.7.3 Enterome Bioscience Microbiome Therapeutics Market Performance (2014-2019)
3.7.4 Enterome Bioscience Business Overview
3.8 Advanced Technology Ventures
3.8.1 Advanced Technology Ventures Basic Information, Manufacturing Base, Sales Area and Competitors
3.8.2 Microbiome Therapeutics Product Profiles, Application and Specification
3.8.3 Advanced Technology Ventures Microbiome Therapeutics Market Performance (2014-2019)
3.8.4 Advanced Technology Ventures Business Overview
3.9 Immuron
3.9.1 Immuron Basic Information, Manufacturing Base, Sales Area and Competitors
3.9.2 Microbiome Therapeutics Product Profiles, Application and Specification
3.9.3 Immuron Microbiome Therapeutics Market Performance (2014-2019)
3.9.4 Immuron Business Overview
3.10 Azitra
3.10.1 Azitra Basic Information, Manufacturing Base, Sales Area and Competitors
3.10.2 Microbiome Therapeutics Product Profiles, Application and Specification
3.10.3 Azitra Microbiome Therapeutics Market Performance (2014-2019)
3.10.4 Azitra Business Overview
3.11 Osel
3.11.1 Osel Basic Information, Manufacturing Base, Sales Area and Competitors
3.11.2 Microbiome Therapeutics Product Profiles, Application and Specification
3.11.3 Osel Microbiome Therapeutics Market Performance (2014-2019)
3.11.4 Osel Business Overview
3.12 Synthetic Biologics
3.12.1 Synthetic Biologics Basic Information, Manufacturing Base, Sales Area and Competitors
3.12.2 Microbiome Therapeutics Product Profiles, Application and Specification
3.12.3 Synthetic Biologics Microbiome Therapeutics Market Performance (2014-2019)
3.12.4 Synthetic Biologics Business Overview
3.13 ActoGeniX
3.13.1 ActoGeniX Basic Information, Manufacturing Base, Sales Area and Competitors
3.13.2 Microbiome Therapeutics Product Profiles, Application and Specification
3.13.3 ActoGeniX Microbiome Therapeutics Market Performance (2014-2019)
3.13.4 ActoGeniX Business Overview
3.14 C3 Jian
3.14.1 C3 Jian Basic Information, Manufacturing Base, Sales Area and Competitors
3.14.2 Microbiome Therapeutics Product Profiles, Application and Specification
3.14.3 C3 Jian Microbiome Therapeutics Market Performance (2014-2019)
3.14.4 C3 Jian Business Overview
3.15 4D Pharma
3.15.1 4D Pharma Basic Information, Manufacturing Base, Sales Area and Competitors
3.15.2 Microbiome Therapeutics Product Profiles, Application and Specification
3.15.3 4D Pharma Microbiome Therapeutics Market Performance (2014-2019)
3.15.4 4D Pharma Business Overview
3.16 AOBiome
3.16.1 AOBiome Basic Information, Manufacturing Base, Sales Area and Competitors
3.16.2 Microbiome Therapeutics Product Profiles, Application and Specification
3.16.3 AOBiome Microbiome Therapeutics Market Performance (2014-2019)
3.16.4 AOBiome Business Overview
3.17 Ritter Pharmaceuticals
3.17.1 Ritter Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Competitors
3.17.2 Microbiome Therapeutics Product Profiles, Application and Specification
3.17.3 Ritter Pharmaceuticals Microbiome Therapeutics Market Performance (2014-2019)
3.17.4 Ritter Pharmaceuticals Business Overview
3.18 OpenBiome
3.18.1 OpenBiome Basic Information, Manufacturing Base, Sales Area and Competitors
3.18.2 Microbiome Therapeutics Product Profiles, Application and Specification
3.18.3 OpenBiome Microbiome Therapeutics Market Performance (2014-2019)
3.18.4 OpenBiome Business Overview
3.19 Advancing Bio
3.19.1 Advancing Bio Basic Information, Manufacturing Base, Sales Area and Competitors
3.19.2 Microbiome Therapeutics Product Profiles, Application and Specification
3.19.3 Advancing Bio Microbiome Therapeutics Market Performance (2014-2019)
3.19.4 Advancing Bio Business Overview
3.20 Seres Therapeutics
3.20.1 Seres Therapeutics Basic Information, Manufacturing Base, Sales Area and Competitors
3.20.2 Microbiome Therapeutics Product Profiles, Application and Specification
3.20.3 Seres Therapeutics Microbiome Therapeutics Market Performance (2014-2019)
3.20.4 Seres Therapeutics Business Overview
3.21 Second Genome
3.21.1 Second Genome Basic Information, Manufacturing Base, Sales Area and Competitors
3.21.2 Microbiome Therapeutics Product Profiles, Application and Specification
3.21.3 Second Genome Microbiome Therapeutics Market Performance (2014-2019)
3.21.4 Second Genome Business Overview
3.22 Avid Biotics
3.22.1 Avid Biotics Basic Information, Manufacturing Base, Sales Area and Competitors
3.22.2 Microbiome Therapeutics Product Profiles, Application and Specification
3.22.3 Avid Biotics Microbiome Therapeutics Market Performance (2014-2019)
3.22.4 Avid Biotics Business Overview
4 GLOBAL MICROBIOME THERAPEUTICS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE
4.1 Global Microbiome Therapeutics Production and Market Share by Type (2014-2019)
4.2 Global Microbiome Therapeutics Revenue and Market Share by Type (2014-2019)
4.3 Global Microbiome Therapeutics Price by Type (2014-2019)
4.4 Global Microbiome Therapeutics Production Growth Rate by Type (2014-2019)
4.4.1 Global Microbiome Therapeutics Production Growth Rate of Fructo-Oligosaccharides (2014-2019)
4.4.2 Global Microbiome Therapeutics Production Growth Rate of Galacto-Oligosaccharides (2014-2019)
4.4.3 Global Microbiome Therapeutics Production Growth Rate of Inulin (2014-2019)
5 GLOBAL MICROBIOME THERAPEUTICS MARKET ANALYSIS BY APPLICATION
5.1 Global Microbiome Therapeutics Consumption and Market Share by Application (2014-2019)
5.2 Global Microbiome Therapeutics Consumption Growth Rate by Application (2014-2019)
5.2.1 Global Microbiome Therapeutics Consumption Growth Rate of Antibiotic-Associated Diarrhoea (AAD) (2014-2019)
5.2.2 Global Microbiome Therapeutics Consumption Growth Rate of Infectious Childhood Diarrhoea (2014-2019)
5.2.3 Global Microbiome Therapeutics Consumption Growth Rate of Cholesterol (2014-2019)
5.2.4 Global Microbiome Therapeutics Consumption Growth Rate of Inflammatory Bowel Disease (IBD) (2014-2019)
5.2.5 Global Microbiome Therapeutics Consumption Growth Rate of Blood Pressure (2014-2019)
5.2.6 Global Microbiome Therapeutics Consumption Growth Rate of Lactose Intolerance (2014-2019)
5.2.7 Global Microbiome Therapeutics Consumption Growth Rate of Weight Loss (2014-2019)
5.2.8 Global Microbiome Therapeutics Consumption Growth Rate of Vitamin Production (2014-2019)
5.2.9 Global Microbiome Therapeutics Consumption Growth Rate of Bacterial Vaginosis (BV) (2014-2019)
5.2.10 Global Microbiome Therapeutics Consumption Growth Rate of Others (2014-2019)
6 GLOBAL MICROBIOME THERAPEUTICS PRODUCTION, CONSUMPTION, EXPORT, IMPORT BY REGION (2014-2019)
6.1 Global Microbiome Therapeutics Consumption by Region (2014-2019)
6.2 United States Microbiome Therapeutics Production, Consumption, Export, Import (2014-2019)
6.3 Europe Microbiome Therapeutics Production, Consumption, Export, Import (2014-2019)
6.4 China Microbiome Therapeutics Production, Consumption, Export, Import (2014-2019)
6.5 Japan Microbiome Therapeutics Production, Consumption, Export, Import (2014-2019)
6.6 India Microbiome Therapeutics Production, Consumption, Export, Import (2014-2019)
6.7 Southeast Asia Microbiome Therapeutics Production, Consumption, Export, Import (2014-2019)
6.8 Central and South America Microbiome Therapeutics Production, Consumption, Export, Import (2014-2019)
6.9 Middle East and Africa Microbiome Therapeutics Production, Consumption, Export, Import (2014-2019)
7 GLOBAL MICROBIOME THERAPEUTICS PRODUCTION, REVENUE (VALUE) BY REGION (2014-2019)
7.1 Global Microbiome Therapeutics Production and Market Share by Region (2014-2019)
7.2 Global Microbiome Therapeutics Revenue (Value) and Market Share by Region (2014-2019)
7.3 Global Microbiome Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
7.4 United States Microbiome Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
7.5 Europe Microbiome Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
7.6 China Microbiome Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
7.7 Japan Microbiome Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
7.8 India Microbiome Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
7.9 Southeast Asia Microbiome Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
7.10 Central and South America Microbiome Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
7.11 Middle East and Africa Microbiome Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
8 MICROBIOME THERAPEUTICS MANUFACTURING ANALYSIS
8.1 Microbiome Therapeutics Key Raw Materials Analysis
8.1.1 Key Raw Materials Introduction
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Manufacturing Cost Analysis
8.2.1 Labor Cost Analysis
8.2.2 Manufacturing Cost Structure Analysis
8.3 Manufacturing Process Analysis of Microbiome Therapeutics
9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
9.1 Microbiome Therapeutics Industrial Chain Analysis
9.2 Raw Materials Sources of Microbiome Therapeutics Major Players in 2018
9.3 Downstream Buyers
10 MARKET DYNAMICS
10.1 Drivers
10.2 Restraints
10.3 Opportunities
10.3.1 Advances in Innovation and Technology for Microbiome Therapeutics
10.3.2 Increased Demand in Emerging Markets
10.4 Challenges
10.4.1 The Performance of Alternative Product Type is Getting Better and Better
10.4.2 Price Variance Caused by Fluctuations in Raw Material Prices
10.5 Porter?s Five Forces Analysis
10.5.1 Threat of New Entrants
10.5.2 Threat of Substitutes
10.5.3 Bargaining Power of Suppliers
10.5.4 Bargaining Power of Buyers
10.5.5 Intensity of Competitive Rivalry
11 GLOBAL MICROBIOME THERAPEUTICS MARKET FORECAST (2019-2026)
11.1 Global Microbiome Therapeutics Production, Revenue Forecast (2019-2026)
11.1.1 Global Microbiome Therapeutics Production and Growth Rate Forecast (2019-2026)
11.1.2 Global Microbiome Therapeutics Revenue and Growth Rate Forecast (2019-2026)
11.1.3 Global Microbiome Therapeutics Price and Trend Forecast (2019-2026)
11.2 Global Microbiome Therapeutics Production, Consumption, Export and Import Forecast by Region (2019-2026)
11.2.1 United States Microbiome Therapeutics Production, Consumption, Export and Import Forecast (2019-2026)
11.2.2 Europe Microbiome Therapeutics Production, Consumption, Export and Import Forecast (2019-2026)
11.2.3 China Microbiome Therapeutics Production, Consumption, Export and Import Forecast (2019-2026)
11.2.4 Japan Microbiome Therapeutics Production, Consumption, Export and Import Forecast (2019-2026)
11.2.5 India Microbiome Therapeutics Production, Consumption, Export and Import Forecast (2019-2026)
11.2.6 Southeast Asia Microbiome Therapeutics Production, Consumption, Export and Import Forecast (2019-2026)
11.2.7 Central and South America Microbiome Therapeutics Production, Consumption, Export and Import Forecast (2019-2026)
11.2.8 Middle East and Africa Microbiome Therapeutics Production, Consumption, Export and Import Forecast (2019-2026)
11.3 Global Microbiome Therapeutics Production, Revenue and Price Forecast by Type (2019-2026)
11.4 Global Microbiome Therapeutics Consumption Forecast by Application (2019-2026)
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Data Source
1.1 Product Overview and Scope of Microbiome Therapeutics
1.2 Microbiome Therapeutics Segment by Type
1.2.1 Global Microbiome Therapeutics Production and CAGR (%) Comparison by Type (2014-2026)
1.2.2 The Market Profile of Fructo-Oligosaccharides
1.2.3 The Market Profile of Galacto-Oligosaccharides
1.2.4 The Market Profile of Inulin
1.3 Global Microbiome Therapeutics Segment by Application
1.3.1 Microbiome Therapeutics Consumption (Sales) Comparison by Application (2014-2026)
1.3.2 The Market Profile of Antibiotic-Associated Diarrhoea (AAD)
1.3.3 The Market Profile of Infectious Childhood Diarrhoea
1.3.4 The Market Profile of Cholesterol
1.3.5 The Market Profile of Inflammatory Bowel Disease (IBD)
1.3.6 The Market Profile of Blood Pressure
1.3.7 The Market Profile of Lactose Intolerance
1.3.8 The Market Profile of Weight Loss
1.3.9 The Market Profile of Vitamin Production
1.3.10 The Market Profile of Bacterial Vaginosis (BV)
1.3.11 The Market Profile of Others
1.4 Global Microbiome Therapeutics Market by Region (2014-2026)
1.4.1 Global Microbiome Therapeutics Market Size (Value) and CAGR (%) Comparison by Region (2014-2026)
1.4.2 United States Microbiome Therapeutics Market Status and Prospect (2014-2026)
1.4.3 Europe Microbiome Therapeutics Market Status and Prospect (2014-2026)
1.4.3.1 Germany Microbiome Therapeutics Market Status and Prospect (2014-2026)
1.4.3.2 UK Microbiome Therapeutics Market Status and Prospect (2014-2026)
1.4.3.3 France Microbiome Therapeutics Market Status and Prospect (2014-2026)
1.4.3.4 Italy Microbiome Therapeutics Market Status and Prospect (2014-2026)
1.4.3.5 Spain Microbiome Therapeutics Market Status and Prospect (2014-2026)
1.4.3.6 Russia Microbiome Therapeutics Market Status and Prospect (2014-2026)
1.4.3.7 Poland Microbiome Therapeutics Market Status and Prospect (2014-2026)
1.4.4 China Microbiome Therapeutics Market Status and Prospect (2014-2026)
1.4.5 Japan Microbiome Therapeutics Market Status and Prospect (2014-2026)
1.4.6 India Microbiome Therapeutics Market Status and Prospect (2014-2026)
1.4.7 Southeast Asia Microbiome Therapeutics Market Status and Prospect (2014-2026)
1.4.7.1 Malaysia Microbiome Therapeutics Market Status and Prospect (2014-2026)
1.4.7.2 Singapore Microbiome Therapeutics Market Status and Prospect (2014-2026)
1.4.7.3 Philippines Microbiome Therapeutics Market Status and Prospect (2014-2026)
1.4.7.4 Indonesia Microbiome Therapeutics Market Status and Prospect (2014-2026)
1.4.7.5 Thailand Microbiome Therapeutics Market Status and Prospect (2014-2026)
1.4.7.6 Vietnam Microbiome Therapeutics Market Status and Prospect (2014-2026)
1.4.8 Central and South America Microbiome Therapeutics Market Status and Prospect (2014-2026)
1.4.8.1 Brazil Microbiome Therapeutics Market Status and Prospect (2014-2026)
1.4.8.2 Mexico Microbiome Therapeutics Market Status and Prospect (2014-2026)
1.4.8.3 Colombia Microbiome Therapeutics Market Status and Prospect (2014-2026)
1.4.9 Middle East and Africa Microbiome Therapeutics Market Status and Prospect (2014-2026)
1.4.9.1 Saudi Arabia Microbiome Therapeutics Market Status and Prospect (2014-2026)
1.4.9.2 United Arab Emirates Microbiome Therapeutics Market Status and Prospect (2014-2026)
1.4.9.3 Turkey Microbiome Therapeutics Market Status and Prospect (2014-2026)
1.4.9.4 Egypt Microbiome Therapeutics Market Status and Prospect (2014-2026)
1.4.9.5 South Africa Microbiome Therapeutics Market Status and Prospect (2014-2026)
1.4.9.6 Nigeria Microbiome Therapeutics Market Status and Prospect (2014-2026)
1.5 Global Market Size (Value) of Microbiome Therapeutics (2014-2026)
1.5.1 Global Microbiome Therapeutics Revenue Status and Outlook (2014-2026)
1.5.2 Global Microbiome Therapeutics Production Status and Outlook (2014-2026)
2 GLOBAL MICROBIOME THERAPEUTICS MARKET LANDSCAPE BY PLAYER
2.1 Global Microbiome Therapeutics Production and Share by Player (2014-2019)
2.2 Global Microbiome Therapeutics Revenue and Market Share by Player (2014-2019)
2.3 Global Microbiome Therapeutics Average Price by Player (2014-2019)
2.4 Microbiome Therapeutics Manufacturing Base Distribution, Sales Area and Product Type by Player
2.5 Microbiome Therapeutics Market Competitive Situation and Trends
2.5.1 Microbiome Therapeutics Market Concentration Rate
2.5.2 Microbiome Therapeutics Market Share of Top 3 and Top 6 Players
2.5.3 Mergers & Acquisitions, Expansion
3 PLAYERS PROFILES
3.1 Assembly Biosciences
3.1.1 Assembly Biosciences Basic Information, Manufacturing Base, Sales Area and Competitors
3.1.2 Microbiome Therapeutics Product Profiles, Application and Specification
3.1.3 Assembly Biosciences Microbiome Therapeutics Market Performance (2014-2019)
3.1.4 Assembly Biosciences Business Overview
3.2 MicroBiome Therapeutics
3.2.1 MicroBiome Therapeutics Basic Information, Manufacturing Base, Sales Area and Competitors
3.2.2 Microbiome Therapeutics Product Profiles, Application and Specification
3.2.3 MicroBiome Therapeutics Microbiome Therapeutics Market Performance (2014-2019)
3.2.4 MicroBiome Therapeutics Business Overview
3.3 APC Microbiome Institute
3.3.1 APC Microbiome Institute Basic Information, Manufacturing Base, Sales Area and Competitors
3.3.2 Microbiome Therapeutics Product Profiles, Application and Specification
3.3.3 APC Microbiome Institute Microbiome Therapeutics Market Performance (2014-2019)
3.3.4 APC Microbiome Institute Business Overview
3.4 AgBiome
3.4.1 AgBiome Basic Information, Manufacturing Base, Sales Area and Competitors
3.4.2 Microbiome Therapeutics Product Profiles, Application and Specification
3.4.3 AgBiome Microbiome Therapeutics Market Performance (2014-2019)
3.4.4 AgBiome Business Overview
3.5 Admera Health
3.5.1 Admera Health Basic Information, Manufacturing Base, Sales Area and Competitors
3.5.2 Microbiome Therapeutics Product Profiles, Application and Specification
3.5.3 Admera Health Microbiome Therapeutics Market Performance (2014-2019)
3.5.4 Admera Health Business Overview
3.6 AbbVie
3.6.1 AbbVie Basic Information, Manufacturing Base, Sales Area and Competitors
3.6.2 Microbiome Therapeutics Product Profiles, Application and Specification
3.6.3 AbbVie Microbiome Therapeutics Market Performance (2014-2019)
3.6.4 AbbVie Business Overview
3.7 Enterome Bioscience
3.7.1 Enterome Bioscience Basic Information, Manufacturing Base, Sales Area and Competitors
3.7.2 Microbiome Therapeutics Product Profiles, Application and Specification
3.7.3 Enterome Bioscience Microbiome Therapeutics Market Performance (2014-2019)
3.7.4 Enterome Bioscience Business Overview
3.8 Advanced Technology Ventures
3.8.1 Advanced Technology Ventures Basic Information, Manufacturing Base, Sales Area and Competitors
3.8.2 Microbiome Therapeutics Product Profiles, Application and Specification
3.8.3 Advanced Technology Ventures Microbiome Therapeutics Market Performance (2014-2019)
3.8.4 Advanced Technology Ventures Business Overview
3.9 Immuron
3.9.1 Immuron Basic Information, Manufacturing Base, Sales Area and Competitors
3.9.2 Microbiome Therapeutics Product Profiles, Application and Specification
3.9.3 Immuron Microbiome Therapeutics Market Performance (2014-2019)
3.9.4 Immuron Business Overview
3.10 Azitra
3.10.1 Azitra Basic Information, Manufacturing Base, Sales Area and Competitors
3.10.2 Microbiome Therapeutics Product Profiles, Application and Specification
3.10.3 Azitra Microbiome Therapeutics Market Performance (2014-2019)
3.10.4 Azitra Business Overview
3.11 Osel
3.11.1 Osel Basic Information, Manufacturing Base, Sales Area and Competitors
3.11.2 Microbiome Therapeutics Product Profiles, Application and Specification
3.11.3 Osel Microbiome Therapeutics Market Performance (2014-2019)
3.11.4 Osel Business Overview
3.12 Synthetic Biologics
3.12.1 Synthetic Biologics Basic Information, Manufacturing Base, Sales Area and Competitors
3.12.2 Microbiome Therapeutics Product Profiles, Application and Specification
3.12.3 Synthetic Biologics Microbiome Therapeutics Market Performance (2014-2019)
3.12.4 Synthetic Biologics Business Overview
3.13 ActoGeniX
3.13.1 ActoGeniX Basic Information, Manufacturing Base, Sales Area and Competitors
3.13.2 Microbiome Therapeutics Product Profiles, Application and Specification
3.13.3 ActoGeniX Microbiome Therapeutics Market Performance (2014-2019)
3.13.4 ActoGeniX Business Overview
3.14 C3 Jian
3.14.1 C3 Jian Basic Information, Manufacturing Base, Sales Area and Competitors
3.14.2 Microbiome Therapeutics Product Profiles, Application and Specification
3.14.3 C3 Jian Microbiome Therapeutics Market Performance (2014-2019)
3.14.4 C3 Jian Business Overview
3.15 4D Pharma
3.15.1 4D Pharma Basic Information, Manufacturing Base, Sales Area and Competitors
3.15.2 Microbiome Therapeutics Product Profiles, Application and Specification
3.15.3 4D Pharma Microbiome Therapeutics Market Performance (2014-2019)
3.15.4 4D Pharma Business Overview
3.16 AOBiome
3.16.1 AOBiome Basic Information, Manufacturing Base, Sales Area and Competitors
3.16.2 Microbiome Therapeutics Product Profiles, Application and Specification
3.16.3 AOBiome Microbiome Therapeutics Market Performance (2014-2019)
3.16.4 AOBiome Business Overview
3.17 Ritter Pharmaceuticals
3.17.1 Ritter Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Competitors
3.17.2 Microbiome Therapeutics Product Profiles, Application and Specification
3.17.3 Ritter Pharmaceuticals Microbiome Therapeutics Market Performance (2014-2019)
3.17.4 Ritter Pharmaceuticals Business Overview
3.18 OpenBiome
3.18.1 OpenBiome Basic Information, Manufacturing Base, Sales Area and Competitors
3.18.2 Microbiome Therapeutics Product Profiles, Application and Specification
3.18.3 OpenBiome Microbiome Therapeutics Market Performance (2014-2019)
3.18.4 OpenBiome Business Overview
3.19 Advancing Bio
3.19.1 Advancing Bio Basic Information, Manufacturing Base, Sales Area and Competitors
3.19.2 Microbiome Therapeutics Product Profiles, Application and Specification
3.19.3 Advancing Bio Microbiome Therapeutics Market Performance (2014-2019)
3.19.4 Advancing Bio Business Overview
3.20 Seres Therapeutics
3.20.1 Seres Therapeutics Basic Information, Manufacturing Base, Sales Area and Competitors
3.20.2 Microbiome Therapeutics Product Profiles, Application and Specification
3.20.3 Seres Therapeutics Microbiome Therapeutics Market Performance (2014-2019)
3.20.4 Seres Therapeutics Business Overview
3.21 Second Genome
3.21.1 Second Genome Basic Information, Manufacturing Base, Sales Area and Competitors
3.21.2 Microbiome Therapeutics Product Profiles, Application and Specification
3.21.3 Second Genome Microbiome Therapeutics Market Performance (2014-2019)
3.21.4 Second Genome Business Overview
3.22 Avid Biotics
3.22.1 Avid Biotics Basic Information, Manufacturing Base, Sales Area and Competitors
3.22.2 Microbiome Therapeutics Product Profiles, Application and Specification
3.22.3 Avid Biotics Microbiome Therapeutics Market Performance (2014-2019)
3.22.4 Avid Biotics Business Overview
4 GLOBAL MICROBIOME THERAPEUTICS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE
4.1 Global Microbiome Therapeutics Production and Market Share by Type (2014-2019)
4.2 Global Microbiome Therapeutics Revenue and Market Share by Type (2014-2019)
4.3 Global Microbiome Therapeutics Price by Type (2014-2019)
4.4 Global Microbiome Therapeutics Production Growth Rate by Type (2014-2019)
4.4.1 Global Microbiome Therapeutics Production Growth Rate of Fructo-Oligosaccharides (2014-2019)
4.4.2 Global Microbiome Therapeutics Production Growth Rate of Galacto-Oligosaccharides (2014-2019)
4.4.3 Global Microbiome Therapeutics Production Growth Rate of Inulin (2014-2019)
5 GLOBAL MICROBIOME THERAPEUTICS MARKET ANALYSIS BY APPLICATION
5.1 Global Microbiome Therapeutics Consumption and Market Share by Application (2014-2019)
5.2 Global Microbiome Therapeutics Consumption Growth Rate by Application (2014-2019)
5.2.1 Global Microbiome Therapeutics Consumption Growth Rate of Antibiotic-Associated Diarrhoea (AAD) (2014-2019)
5.2.2 Global Microbiome Therapeutics Consumption Growth Rate of Infectious Childhood Diarrhoea (2014-2019)
5.2.3 Global Microbiome Therapeutics Consumption Growth Rate of Cholesterol (2014-2019)
5.2.4 Global Microbiome Therapeutics Consumption Growth Rate of Inflammatory Bowel Disease (IBD) (2014-2019)
5.2.5 Global Microbiome Therapeutics Consumption Growth Rate of Blood Pressure (2014-2019)
5.2.6 Global Microbiome Therapeutics Consumption Growth Rate of Lactose Intolerance (2014-2019)
5.2.7 Global Microbiome Therapeutics Consumption Growth Rate of Weight Loss (2014-2019)
5.2.8 Global Microbiome Therapeutics Consumption Growth Rate of Vitamin Production (2014-2019)
5.2.9 Global Microbiome Therapeutics Consumption Growth Rate of Bacterial Vaginosis (BV) (2014-2019)
5.2.10 Global Microbiome Therapeutics Consumption Growth Rate of Others (2014-2019)
6 GLOBAL MICROBIOME THERAPEUTICS PRODUCTION, CONSUMPTION, EXPORT, IMPORT BY REGION (2014-2019)
6.1 Global Microbiome Therapeutics Consumption by Region (2014-2019)
6.2 United States Microbiome Therapeutics Production, Consumption, Export, Import (2014-2019)
6.3 Europe Microbiome Therapeutics Production, Consumption, Export, Import (2014-2019)
6.4 China Microbiome Therapeutics Production, Consumption, Export, Import (2014-2019)
6.5 Japan Microbiome Therapeutics Production, Consumption, Export, Import (2014-2019)
6.6 India Microbiome Therapeutics Production, Consumption, Export, Import (2014-2019)
6.7 Southeast Asia Microbiome Therapeutics Production, Consumption, Export, Import (2014-2019)
6.8 Central and South America Microbiome Therapeutics Production, Consumption, Export, Import (2014-2019)
6.9 Middle East and Africa Microbiome Therapeutics Production, Consumption, Export, Import (2014-2019)
7 GLOBAL MICROBIOME THERAPEUTICS PRODUCTION, REVENUE (VALUE) BY REGION (2014-2019)
7.1 Global Microbiome Therapeutics Production and Market Share by Region (2014-2019)
7.2 Global Microbiome Therapeutics Revenue (Value) and Market Share by Region (2014-2019)
7.3 Global Microbiome Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
7.4 United States Microbiome Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
7.5 Europe Microbiome Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
7.6 China Microbiome Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
7.7 Japan Microbiome Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
7.8 India Microbiome Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
7.9 Southeast Asia Microbiome Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
7.10 Central and South America Microbiome Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
7.11 Middle East and Africa Microbiome Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
8 MICROBIOME THERAPEUTICS MANUFACTURING ANALYSIS
8.1 Microbiome Therapeutics Key Raw Materials Analysis
8.1.1 Key Raw Materials Introduction
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Manufacturing Cost Analysis
8.2.1 Labor Cost Analysis
8.2.2 Manufacturing Cost Structure Analysis
8.3 Manufacturing Process Analysis of Microbiome Therapeutics
9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
9.1 Microbiome Therapeutics Industrial Chain Analysis
9.2 Raw Materials Sources of Microbiome Therapeutics Major Players in 2018
9.3 Downstream Buyers
10 MARKET DYNAMICS
10.1 Drivers
10.2 Restraints
10.3 Opportunities
10.3.1 Advances in Innovation and Technology for Microbiome Therapeutics
10.3.2 Increased Demand in Emerging Markets
10.4 Challenges
10.4.1 The Performance of Alternative Product Type is Getting Better and Better
10.4.2 Price Variance Caused by Fluctuations in Raw Material Prices
10.5 Porter?s Five Forces Analysis
10.5.1 Threat of New Entrants
10.5.2 Threat of Substitutes
10.5.3 Bargaining Power of Suppliers
10.5.4 Bargaining Power of Buyers
10.5.5 Intensity of Competitive Rivalry
11 GLOBAL MICROBIOME THERAPEUTICS MARKET FORECAST (2019-2026)
11.1 Global Microbiome Therapeutics Production, Revenue Forecast (2019-2026)
11.1.1 Global Microbiome Therapeutics Production and Growth Rate Forecast (2019-2026)
11.1.2 Global Microbiome Therapeutics Revenue and Growth Rate Forecast (2019-2026)
11.1.3 Global Microbiome Therapeutics Price and Trend Forecast (2019-2026)
11.2 Global Microbiome Therapeutics Production, Consumption, Export and Import Forecast by Region (2019-2026)
11.2.1 United States Microbiome Therapeutics Production, Consumption, Export and Import Forecast (2019-2026)
11.2.2 Europe Microbiome Therapeutics Production, Consumption, Export and Import Forecast (2019-2026)
11.2.3 China Microbiome Therapeutics Production, Consumption, Export and Import Forecast (2019-2026)
11.2.4 Japan Microbiome Therapeutics Production, Consumption, Export and Import Forecast (2019-2026)
11.2.5 India Microbiome Therapeutics Production, Consumption, Export and Import Forecast (2019-2026)
11.2.6 Southeast Asia Microbiome Therapeutics Production, Consumption, Export and Import Forecast (2019-2026)
11.2.7 Central and South America Microbiome Therapeutics Production, Consumption, Export and Import Forecast (2019-2026)
11.2.8 Middle East and Africa Microbiome Therapeutics Production, Consumption, Export and Import Forecast (2019-2026)
11.3 Global Microbiome Therapeutics Production, Revenue and Price Forecast by Type (2019-2026)
11.4 Global Microbiome Therapeutics Consumption Forecast by Application (2019-2026)
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Data Source
